JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shafer, R. W.
Right arrow Articles by Brendel, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shafer, R. W.
Right arrow Articles by Brendel, V.

Journal of Virology, July 1999, p. 6197-6202, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Identification of Biased Amino Acid Substitution Patterns in Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Protease Inhibitors

Robert W. Shafer,1,* Phillip Hsu,2 Amy K. Patick,3 Charles Craig,4 and Volker Brendel5

Division of Infectious Diseases, Stanford University Medical Center,1 and Stanford University,2 Stanford, California 94305; Agouron Pharmaceuticals, Inc., San Diego, California 921213; Department of Zoology and Genetics, Iowa State University, Ames, Iowa 50011-32605; and Roche Discovery Welwyn, Welwyn Garden City, Hertsfordshire, United Kingdom4

Received 21 July 1998/Accepted 26 March 1999

Human immunodeficiency virus type 1 (HIV-1) amino acid substitutions observed during antiretroviral drug therapy may be caused by drug selection, non-drug-related evolution, or sampling error introduced by the sequencing process. We analyzed HIV-1 sequences from 371 untreated patients and from 178 patients receiving a single protease inhibitor. Amino acid substitution patterns during treatment were compared with inferred substitution patterns arising evolutionarily without treatment. Our results suggest that most treatment-associated amino acid substitutions are caused by selective drug pressure, including substitutions not previously associated with drug resistance.

* Corresponding author. Mailing address: Division of Infectious Diseases, S-156, Stanford University Medical Center, Room S156, 300 Pasteur Dr., Stanford, CA 94305-5107. Phone: (650) 725-2946. Fax: (650) 725-2395. E-mail: rshafer{at}cmgm.stanford.edu.

Journal of Virology, July 1999, p. 6197-6202, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1999 by the American Society for Microbiology. All rights reserved.